$0.4637
-0.0222-4.56%
Last update: Nov 10, 12:11 PM
Neumora Therapeutics Inc
NMRANASDAQ
Neumora Therapeutics fell 82.7% from $2.81 to $0.49, behind the S&P 500's +10.5%. Its worst day was Jun 15 (−48.6%), and its low came Oct 14 at $0.35.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Neumora Therapeutics shares rose 25.8%, while the S&P 500 fell 0.3%.
+25.8% · S&P 500 −0.3%
Neumora Therapeutics shares rose 25.1%, while the S&P 500 fell 0.3%.
+25.1% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
Neumora Therapeutics closed at its highest level of the year, 27.8% above where the year started.
+1.4% · S&P 500 +0.5%
EPS of $-0.35 missed the $-0.33 estimate on $0.00 revenue.
−17.2% · S&P 500 −0.3%
EPS of $-0.30 beat the $-0.31 estimate on $0.00 revenue.
−16.7% · S&P 500 −0.3%
Neumora Therapeutics shares rose 70.6%, while the S&P 500 fell 0.6%.
+70.6%, the year's best day, on 29M shares, the year's heaviest volume · S&P 500 −0.6%
EPS of $-0.23 beat the $-0.24 estimate on $0.00 revenue.
−7.5% · S&P 500 −0.2%
Neumora Therapeutics closed at its lowest level of the year, 87.4% below where the year started.
−4.2% · S&P 500 −1.1%
Neumora Therapeutics shares rose 35.0%, while the S&P 500 fell 0.5%.
+35.0% · S&P 500 −0.5%
Where it ended: a close of $0.49 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.19).
Nothing in the past 12 months.
All NMRA dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NMRA and SPY from Benzinga historical bars. Not investment advice.
